Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- 最新申報
- 2026/8/13
2021 年第 1 季持倉
持倉截至 2021/3/31，2021/5/14 申報。只含多頭部位。
- 持股檔數
- 62
- 2020 年第 4 季沒有 13F 資料
- 總值
- $2.04 億
- 2020 年第 4 季沒有 13F 資料
Livermore 的 13F 資料從 2021 年第 1 季開始，這一季沒有前一季可以比較，所以不顯示股數變化與動作。
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| BBIOBridgeBio Pharma, Inc. | COM | 577,500 | $3,557 萬 | 17.4% | – | – | 歷史 |
| MORFMorphic Holding, Inc. | COM | 195,000 | $1,234 萬 | 6.0% | – | – | 歷史 |
| CRISCuris Inc | COM NEW | 1,000,000 | $1,132 萬 | 5.5% | – | – | 歷史 |
| VINCVincerx Pharma, Inc. | COM NEW | 543,010 | $1,048 萬 | 5.1% | – | – | 歷史 |
| KURAKura Oncology, Inc. | COM | 365,000 | $1,032 萬 | 5.1% | – | – | 歷史 |
| Arya Sciences Acquisition CoG3166W106 | COM CL A | 689,000 | $949.4 萬 | 4.7% | – | – | – |
| ARYDARYA Sciences Acquisition Corp IV | CL A | 700,000 | $733.1 萬 | 3.6% | – | – | 歷史 |
| XLRNAcceleron Pharma Inc | COM | 45,000 | $610.2 萬 | 3.0% | – | – | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 222,267 | $560.1 萬 | 2.7% | – | – | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 220,000 | $549.3 萬 | 2.7% | – | – | 歷史 |
| NARIInari Medical, Inc. | Stock | 50,000 | $535.0 萬 | 2.6% | – | – | 歷史 |
| Retrophin Inc761299AB2 | NOTE 2.500% 9/1 | – | $406.9 萬 | 2.0% | – | – | – |
| SNCEScience 37 Holdings, Inc. | COM | 400,000 | $405.6 萬 | 2.0% | – | – | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 85,000 | $377.1 萬 | 1.8% | – | – | 歷史 |
| OCULOcular Therapeutix, Inc | COM | 227,500 | $373.3 萬 | 1.8% | – | – | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 270,000 | $370.7 萬 | 1.8% | – | – | 歷史 |
| ALDXAldeyra Therapeutics, Inc. | COM | 300,000 | $356.4 萬 | 1.7% | – | – | 歷史 |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 77,500 | $336.3 萬 | 1.6% | – | – | 歷史 |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 35,000 | $322.1 萬 | 1.6% | – | – | 歷史 |
| MREOMereo BioPharma Group plc | SPON ADS | 900,000 | $303.3 萬 | 1.5% | – | – | 歷史 |
| Medicus Sciences AcquisitionG5960S116 | UNIT 99/99/9999 | 300,000 | $295.5 萬 | 1.4% | – | – | – |
| KDNYChinook Therapeutics, Inc. | COM | 175,000 | $272.0 萬 | 1.3% | – | – | 歷史 |
| Bio Green Med Solution, Inc.23254L603 | COM | 380,000 | $270.2 萬 | 1.3% | – | – | – |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 130,000 | $267.8 萬 | 1.3% | – | – | 歷史 |
| EPIXESSA Pharma Inc. | COM NEW | 90,000 | $261.5 萬 | 1.3% | – | – | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 20,000 | $257.8 萬 | 1.3% | – | – | 歷史 |
| KALVKalVista Pharmaceuticals, Inc. | COM | 100,000 | $256.9 萬 | 1.3% | – | – | 歷史 |
| ZYMEZymeworks Inc. | COM | 80,000 | $252.6 萬 | 1.2% | – | – | 歷史 |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 225,000 | $251.8 萬 | 1.2% | – | – | 歷史 |
| LUNGPulmonx Corp | COM | 45,000 | $205.8 萬 | 1.0% | – | – | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 27,000 | $198.6 萬 | 1.0% | – | – | 歷史 |
| STROSutro Biopharma, Inc. | COM | 80,000 | $182.1 萬 | 0.9% | – | – | 歷史 |
| Highcape Cap Acquisition Cor42984L105 | COM CL A | 150,000 | $178.8 萬 | 0.9% | – | – | – |
| BFLYButterfly Network, Inc. | COM CL A | 100,000 | $168.3 萬 | 0.8% | – | – | 歷史 |
| MRSNMersana Therapeutics, Inc. | COM | 85,000 | $137.5 萬 | 0.7% | – | – | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 50,000 | $129.5 萬 | 0.6% | – | – | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 300,000 | $115.2 萬 | 0.6% | – | – | – |
| BCTG Acquisition Corp05492W103 | COM | 100,000 | $111.2 萬 | 0.5% | – | – | – |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 12,500 | $96.4 萬 | 0.5% | – | – | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 40,000 | $93.0 萬 | 0.5% | – | – | 歷史 |
| Vincerx Pharma, Inc.92731L114 | *W EXP 12/24/202 | 218,000 | $88.1 萬 | 0.4% | – | – | – |
| GBTGlobal Blood Therapeutics, Inc. | COM | 20,000 | $81.5 萬 | 0.4% | – | – | 歷史 |
| AFIBAcutus Medical, Inc. | COM | 60,000 | $80.2 萬 | 0.4% | – | – | 歷史 |
| MGNXMacrogenics Inc | COM | 25,000 | $79.6 萬 | 0.4% | – | – | 歷史 |
| Chardan Healthcr Acqstn 2 Co15957T206 | UNIT 99/99/9999 | 75,000 | $78.9 萬 | 0.4% | – | – | – |
| IOVAIovance Biotherapeutics, Inc. | COM | 24,600 | $77.9 萬 | 0.4% | – | – | 歷史 |
| CCCCC4 Therapeutics, Inc. | COM STK | 20,000 | $74.0 萬 | 0.4% | – | – | 歷史 |
| Aslan Pharmaceuticals Ltd04522R101 | ADS | 200,000 | $67.0 萬 | 0.3% | – | – | – |
| XFORX4 Pharmaceuticals, Inc | COM | 75,000 | $64.6 萬 | 0.3% | – | – | 歷史 |
| ESTAEstablishment Labs Holdings Inc. | COM | 10,000 | $62.5 萬 | 0.3% | – | – | 歷史 |
| PCVXVaxcyte, Inc. | COM | 30,000 | $59.3 萬 | 0.3% | – | – | 歷史 |
| Immatics N.V.N44445117 | *W EXP 07/01/202 | 200,000 | $59.0 萬 | 0.3% | – | – | – |
| AXSMAxsome Therapeutics, Inc. | COM | 10,000 | $56.6 萬 | 0.3% | – | – | 歷史 |
| BYSIBeyondSpring Inc. | SHS | 50,000 | $55.4 萬 | 0.3% | – | – | 歷史 |
| EPZMEpizyme, Inc. | COM | 50,000 | $43.6 萬 | 0.2% | – | – | 歷史 |
| HARPHarpoon Therapeutics, Inc. | COM | 20,000 | $41.8 萬 | 0.2% | – | – | 歷史 |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 25,000 | $41.4 萬 | 0.2% | – | – | – |
| CTMXCytomX Therapeutics, Inc. | COM | 50,000 | $38.7 萬 | 0.2% | – | – | 歷史 |
| Cerevel Therapeutics HLDNG I15678U102 | *W EXP 06/09/202 | 72,466 | $31.2 萬 | 0.2% | – | – | – |
| WINTWindtree Therapeutics Inc | COM | 42,847 | $10.5 萬 | 0.1% | – | – | 歷史 |
| Vesper Healthcare Acqstn Cor92538T112 | *W EXP 09/30/202 | 45,000 | $9.40 萬 | <0.1% | – | – | – |
| ZYNEZynerba Pharmaceuticals, Inc. | COM | 13,285 | $6.20 萬 | <0.1% | – | – | 歷史 |
選擇權（10 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| SPYSPDR S&P 500 ETF Trust | ETF | $4,360 萬 | – |
| ARK ETF Tr00214Q302 | GENOMIC REV ETF | $2,130 萬 | – |
| VRTXVertex Pharmaceuticals Inc | Stock | – | $1,075 萬 |
| SNDXSyndax Pharmaceuticals Inc | COM | – | $426.0 萬 |
| CRISCuris Inc | COM NEW | – | $283.0 萬 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | $257.8 萬 | – |
| RUBYRubius Therapeutics, Inc. | COM | – | $185.5 萬 |
| BLUEbluebird bio, Inc. | COM | – | $150.8 萬 |
| IMVTImmunovant, Inc. | COM | – | $112.3 萬 |
| MRNAModerna, Inc. | Stock | – | $65.5 萬 |